Literature DB >> 12916702

Prevalence and characteristics of tinnitus in older adults: the Blue Mountains Hearing Study.

Doungkamol Sindhusake1, Paul Mitchell, Philip Newall, Maryanne Golding, Elena Rochtchina, George Rubin.   

Abstract

There have been few recent estimates of the prevalence of tinnitus from large population-based samples of older persons. Our study aimed to assess the prevalence and characteristics of prolonged tinnitus in a representative sample of 2015 adults aged 55-99 years, residing in the Blue Mountains, west of Sydney, Australia, during 1997-99. All participants underwent a detailed hearing examination by an audiologist, including comprehensive questions about hearing. After age adjustment, subjects reporting tinnitus had significantly worse hearing at both lower and higher frequencies (p < 0.001). This difference was more marked in younger than in older subjects (p < 0.05). Overall, 602 subjects (30.3%) reported having experienced tinnitus, with 48% reporting symptoms in both ears. Tinnitus had been present for at least 6 years in 50% of cases, and most (55%) reported a gradual onset. Despite tinnitus being described as mildly to extremely annoying by 67%, only 37% had sought professional help, and only 6% had received any treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12916702     DOI: 10.3109/14992020309078348

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  38 in total

1.  Body mass index, waist circumference, physical activity, and risk of hearing loss in women.

Authors:  Sharon G Curhan; Roland Eavey; Molin Wang; Meir J Stampfer; Gary C Curhan
Journal:  Am J Med       Date:  2013-10-11       Impact factor: 4.965

Review 2.  Antidepressants for patients with tinnitus.

Authors:  Paolo Baldo; Carolyn Doree; Paola Molin; Don McFerran; Sara Cecco
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 3.  Tinnitus Retraining Therapy (TRT) for tinnitus.

Authors:  John S Phillips; Don McFerran
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 4.  Internet/smartphone-based applications for the treatment of tinnitus: a systematic review.

Authors:  Megha Kondli Nagaraj; Prashanth Prabhu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-05       Impact factor: 2.503

5.  Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.

Authors:  Marilyn F Dille; Dawn Konrad-Martin; Frederick Gallun; Wendy J Helt; Jane S Gordon; Kelly M Reavis; Gene W Bratt; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2010-06       Impact factor: 1.664

6.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Authors:  M Ries; H J Kim; C K Zalewski; M A Mastroianni; D F Moore; R O Brady; J M Dambrosia; R Schiffmann; C C Brewer
Journal:  Brain       Date:  2006-11-14       Impact factor: 13.501

7.  Tinnitus distress is linked to enhanced resting-state functional connectivity from the limbic system to the auditory cortex.

Authors:  Yu-Chen Chen; Wenqing Xia; Huiyou Chen; Yuan Feng; Jin-Jing Xu; Jian-Ping Gu; Richard Salvi; Xindao Yin
Journal:  Hum Brain Mapp       Date:  2017-01-23       Impact factor: 5.038

8.  Prospective study of alcohol consumption and self-reported hearing loss in women.

Authors:  Sharon G Curhan; Roland Eavey; Molin Wang; Meir J Stampfer; Gary C Curhan
Journal:  Alcohol       Date:  2014-10-31       Impact factor: 2.405

9.  Prevalence, Severity, Exposures, and Treatment Patterns of Tinnitus in the United States.

Authors:  Jay M Bhatt; Harrison W Lin; Neil Bhattacharyya
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-10-01       Impact factor: 6.223

10.  Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study.

Authors:  Mehdi Bakhshaee; Mohammadmehdi Ghasemi; Mahmoodreza Azarpazhooh; Ehsan Khadivi; Saman Rezaei; Mohammadtaghi Shakeri; Mohammadreza Tale
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.